Abstract
Patients with oligosecretory myeloma are often excluded from clinical trials because their disease is difficult to measure on standard tests. Measurement of free light chains is a method to evaluate disease in many of these patients.
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for freeCite
CITATION STYLE
APA
Larson, D., Kyle, R. A., & Rajkumar, S. V. (2012). Prevalence and Monitoring of Oligosecretory Myeloma. New England Journal of Medicine, 367(6), 580–581. https://doi.org/10.1056/nejmc1206740
Readers over time
Readers' Seniority
Readers' Discipline
